527 related articles for article (PubMed ID: 23651796)
21. Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway.
Soromou LW; Chen N; Jiang L; Huo M; Wei M; Chu X; Millimouno FM; Feng H; Sidime Y; Deng X
Biochem Biophys Res Commun; 2012 Mar; 419(2):256-61. PubMed ID: 22342978
[TBL] [Abstract][Full Text] [Related]
22. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury.
Magalhães CB; Riva DR; DePaula LJ; Brando-Lima A; Koatz VL; Leal-Cardoso JH; Zin WA; Faffe DS
J Appl Physiol (1985); 2010 Apr; 108(4):845-51. PubMed ID: 20075264
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of Jolkinolide B on LPS-induced mouse acute lung injury.
Yang H; Li Y; Huo P; Li XO; Kong D; Mu W; Fang W; Li L; Liu N; Fang L; Li H; He C
Int Immunopharmacol; 2015 May; 26(1):119-24. PubMed ID: 25819665
[TBL] [Abstract][Full Text] [Related]
24. Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Cai Z; Liu J; Bian H; Cai J; Zhu G
Arch Pharm Res; 2016 Apr; 39(4):499-507. PubMed ID: 26832323
[TBL] [Abstract][Full Text] [Related]
25. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
26. Fucosterol attenuates lipopolysaccharide-induced acute lung injury in mice.
Li Y; Li X; Liu G; Sun R; Wang L; Wang J; Wang H
J Surg Res; 2015 May; 195(2):515-21. PubMed ID: 25818525
[TBL] [Abstract][Full Text] [Related]
27. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
28. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
[TBL] [Abstract][Full Text] [Related]
29. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of protocatechuic acid on acute lung injury induced by lipopolysaccharide in mice via p38MAPK and NF-κB signal pathways.
Zhang X; Li C; Li J; Xu Y; Guan S; Zhao M
Int Immunopharmacol; 2015 May; 26(1):229-36. PubMed ID: 25841318
[TBL] [Abstract][Full Text] [Related]
31. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
32. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
33. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
34. Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice.
Yu PJ; Li JR; Zhu ZG; Kong HY; Jin H; Zhang JY; Tian YX; Li ZH; Wu XY; Zhang JJ; Wu SG
Eur J Pharmacol; 2013 Jun; 710(1-3):39-48. PubMed ID: 23588118
[TBL] [Abstract][Full Text] [Related]
35. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways.
Zhou E; Li Y; Wei Z; Fu Y; Lei H; Zhang N; Yang Z; Xie G
Int Immunopharmacol; 2014 Sep; 22(1):133-40. PubMed ID: 24975658
[TBL] [Abstract][Full Text] [Related]
36. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Shen Y; Sun Z; Guo X
Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
[TBL] [Abstract][Full Text] [Related]
37. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
38. [The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].
Bi MH; Wang BE; Zheng XX; Li M; Mayer K; Zhang SW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):461-4. PubMed ID: 18687171
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
